Recent Publications:
  • "The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer." Clin. Cancer Res.
  • "Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma." Mol. Cell Proteomics 13:4 1034-49
  • "mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms." Breast Cancer Res. Treat. 144:2 287-98
More publications from the Benz Lab...
Core Technologies:
Bioinformatics >
Chemistry & Mass Spec >
Genomics >
Morphology & Imaging >
Change text size: